These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22241998)

  • 1. Trypanosoma cruzi trans-sialidase in complex with a neutralizing antibody: structure/function studies towards the rational design of inhibitors.
    Buschiazzo A; Muiá R; Larrieux N; Pitcovsky T; Mucci J; Campetella O
    PLoS Pathog; 2012 Jan; 8(1):e1002474. PubMed ID: 22241998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Applicability of Neutralizing Antibodies to Trypanosoma cruzi Trans-sialidase.
    Leguizamón MS
    Methods Mol Biol; 2019; 1955():239-246. PubMed ID: 30868532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T rypanosoma cruzi trans-sialidase as a multifunctional enzyme in Chagas' disease.
    Dc-Rubin SS; Schenkman S
    Cell Microbiol; 2012 Oct; 14(10):1522-30. PubMed ID: 22747789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease.
    Chuenkova M; Pereira ME
    J Exp Med; 1995 May; 181(5):1693-703. PubMed ID: 7722448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymocyte depletion in Trypanosoma cruzi infection is mediated by trans-sialidase-induced apoptosis on nurse cells complex.
    Mucci J; Hidalgo A; Mocetti E; Argibay PF; Leguizamon MS; Campetella O
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3896-901. PubMed ID: 11891302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The trans-sialidase, the major Trypanosoma cruzi virulence factor: Three decades of studies.
    Freire-de-Lima L; Fonseca LM; Oeltmann T; Mendonça-Previato L; Previato JO
    Glycobiology; 2015 Nov; 25(11):1142-9. PubMed ID: 26224786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parasite-host glycan interactions during Trypanosoma cruzi infection: trans-Sialidase rides the show.
    Campetella O; Buscaglia CA; Mucci J; Leguizamón MS
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165692. PubMed ID: 31972227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The crystal structure and mode of action of trans-sialidase, a key enzyme in Trypanosoma cruzi pathogenesis.
    Buschiazzo A; Amaya MF; Cremona ML; Frasch AC; Alzari PM
    Mol Cell; 2002 Oct; 10(4):757-68. PubMed ID: 12419220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies inhibiting Trypanosoma cruzi trans-sialidase activity in sera from human infections.
    Leguizamón MS; Campetella O; Russomando G; Almiron M; Guillen I; Ganzález Cappa SM; Frasch AC
    J Infect Dis; 1994 Dec; 170(6):1570-4. PubMed ID: 7995998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating trans-sialidase activity and trans-sialidase-inhibiting antibodies in Trypanosoma cruzi-infected mice.
    Alcântara-Neves NM; Pontes-de-Carvalho LC
    Parasitol Res; 1995; 81(7):560-4. PubMed ID: 7479647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of glycoproteins targeted by Trypanosoma cruzi trans-sialidase, a virulence factor that disturbs lymphocyte glycosylation.
    Muiá RP; Yu H; Prescher JA; Hellman U; Chen X; Bertozzi CR; Campetella O
    Glycobiology; 2010 Jul; 20(7):833-42. PubMed ID: 20354005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune system pathogenesis is prevented by the neutralization of the systemic trans-sialidase from Trypanosoma cruzi during severe infections.
    Risso MG; Pitcovsky TA; Caccuri RL; Campetella O; Leguizamón MS
    Parasitology; 2007 Apr; 134(Pt 4):503-10. PubMed ID: 17166319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of Active Trans-Sialidase Genes Impairs Egress from Mammalian Host Cells and Generates Highly Attenuated Trypanosoma cruzi Parasites.
    Burle-Caldas GA; Dos Santos NSA; de Castro JT; Mugge FLB; Grazielle-Silva V; Oliveira AER; Pereira MCA; Reis-Cunha JL; Dos Santos AC; Gomes DA; Bartholomeu DC; Moretti NS; Schenkman S; Gazzinelli RT; Teixeira SMR
    mBio; 2022 Feb; 13(1):e0347821. PubMed ID: 35073735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosoma cruzi trans-sialidase as a drug target against Chagas disease (American trypanosomiasis).
    Miller BR; Roitberg AE
    Future Med Chem; 2013 Oct; 5(15):1889-900. PubMed ID: 24144418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of natural selection in shaping genetic variation in a promising Chagas disease drug target: Trypanosoma cruzi trans-sialidase.
    Gallant JP; Lima-Cordón RA; Justi SA; Monroy MC; Viola T; Stevens L
    Infect Genet Evol; 2018 Aug; 62():151-159. PubMed ID: 29684709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive phenotype of Trypanosoma cruzi restricted to a population expressing trans-sialidase.
    Pereira ME; Zhang K; Gong Y; Herrera EM; Ming M
    Infect Immun; 1996 Sep; 64(9):3884-92. PubMed ID: 8751943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional properties of Trypanosoma trans-sialidase.
    Schenkman S; Eichinger D; Pereira ME; Nussenzweig V
    Annu Rev Microbiol; 1994; 48():499-523. PubMed ID: 7826016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theft and Reception of Host Cell's Sialic Acid: Dynamics of
    da Fonseca LM; da Costa KM; Chaves VS; Freire-de-Lima CG; Morrot A; Mendonça-Previato L; Previato JO; Freire-de-Lima L
    Front Immunol; 2019; 10():164. PubMed ID: 30787935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
    Agustí R; París G; Ratier L; Frasch AC; de Lederkremer RM
    Glycobiology; 2004 Jul; 14(7):659-70. PubMed ID: 15070857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. trans-Sialidase neutralizing antibody detection in Trypanosoma cruzi-infected domestic reservoirs.
    Sartor PA; Cardinal MV; Orozco MM; Gürtler RE; Leguizamón MS
    Clin Vaccine Immunol; 2011 Jun; 18(6):984-9. PubMed ID: 21471302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.